MARK C. MILLER - Corporate Board Profile

Accelerate Diagnostics, Inc

Filing Date	Source Excerpt
2013-11-05	Mark C. Miller has served as a Director of the Company since November 5, 2013. He currently serves as Executive Chairman and director of Stericycle (NASDAQ: SRCL), where he was Chief Executive Officer from 1992 to 2012 and Chairman of the Board of Directors from 2008 to 2012.
2014-04-15	Mark C. Miller 58 Director Mark C. Miller 812,810 Includes (i) initial award of option to purchase 69,671 shares of common stock at an exercise price of $13.30 per share, which vests 20% per year over a five-year period with the first installment vesting on November 5, 2014 and (ii) annual award of option to purchase 23,224 shares of common stock at an exercise price of $13.30 per share, which vests in 12 equal monthly installments with the first installment vesting on December 5, 2013.
2015-04-08	Mark C. Miller has served as a Director of the Company since November 5, 2013. He currently serves as Executive Chairman and director of Stericycle (NASDAQ: SRCL), where he was Chief Executive Officer from 1992 to 2012 and Chairman of the Board of Directors from 2008 to 2012. Prior to joining Stericycle, Mr. Miller served as vice president for the Pacific, Asia and Africa in the international division of Abbott Laboratories, a diversified health care company, which he joined in 1976 and where he held a number of management and marketing positions. Mr. Miller formerly served as a director of Ventana Medical Systems, Inc., a developer and supplier of automated diagnostic systems. He received a B.S. degree in computer science from Purdue University, where he graduated Phi Beta Kappa. Mr. Miller was selected by Morningstar, Inc. as its “2009 CEO of the Year.”
2016-04-01	Mark C. Miller 60 Director Mark C. Miller has served as a Director of the Company since November 5, 2013. He currently serves as Executive Chairman and director of Stericycle (NASDAQ: SRCL). The Board maintains a standing Compensation Committee comprised of Messrs. Miller, Patience, Schuler, Strobeck and ten Brink.
2017-04-10	Mark Miller 61 Director ...The Board maintains a standing Compensation Committee comprised of Messrs. Miller, Patience, Schuler, Strobeck and ten Brink...The Compensation Committee met 3 times during the year ended December 31, 2016. ...The following table sets forth the compensation of our directors for serving as our directors for the year ended December 31, 2016: Mark Miller 79,519 79,519
2018-04-12	The following table sets forth the compensation of our directors for serving as our directors for the year ended December 31, 2017: Mark Miller Option Award(1) ($) 161,802 Total ($) 161,802
2019-04-05	Mark C. Miller has served as a Director of the Company since November 5, 2013. The Board maintains a standing Audit Committee comprised of Messrs. ten Brink (Chairman) and Miller and Dr. Strobeck. The Board maintains a standing Nominating and Governance Committee comprised of Messrs. Miller (Chairman) and Schuler and Dr. Watts. The following table sets forth the compensation of our directors for serving as our directors for the year ended December 31, 2018: Mark Miller (5) 115,667(2) 115,667 As of December 31, 2018, Mr. Miller held 135,821 options to purchase shares of our common stock.
2020-04-01	Mark C. Miller has served as a Director of the Company since November 5, 2013. ... The Board maintains a standing Audit Committee comprised of Messrs. ten Brink (Chairman) and Miller and Dr. Strobeck. ... The Board maintains a standing Nominating and Governance Committee comprised of Messrs. Miller (Chairman), Diggelmann, Schuler and Dr. Watts. ... The following table sets forth the compensation of our directors for serving as our directors for the year ended December 31, 2019: Mark C. Miller (6) Option Award (1) ($) 133,904 Total ($) 133,904
2021-04-05	Mark C. Miller 65 Director... The Board has affirmatively determined that directors... Miller... are independent directors... The Board maintains a standing Audit Committee comprised of Messrs. ten Brink (Chairman) and Miller and Dr. Strobeck... The Board maintains a standing Nominating and Governance Committee comprised of Messrs. Miller (Chairman), Diggelmann, Schuler and Dr. Watts... The following table sets forth the compensation of our directors for serving as our directors for the year ended December 31, 2020: Mark C. Miller 58,254 58,254
2022-04-07	Mark C. Miller has served as a Director of the Company since November 5, 2013. ... The Board has affirmatively determined that directors ... Miller ... are “independent directors” ... The Board maintains a standing Audit Committee comprised of Messrs. ten Brink (Chairman), Burris, Miller and Dr. Strobeck. ... The Board maintains a standing Nominating and Governance Committee comprised of Messrs. Miller (Chairman), Schuler and Dr. Watts. ... The following table sets forth the compensation of our directors for serving as our directors for the year ended December 31, 2021: Mark C. Miller 101,567